Lapidot Moshe, Mazzola Emanuele, Bueno Raphael
Division of Thoracic Surgery, Lung Center and International Mesothelioma Program, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Division of Thoracic Surgery, Galilee Medical Center, Nahariya 2210001, Israel.
Cancers (Basel). 2025 Aug 26;17(17):2786. doi: 10.3390/cancers17172786.
: Unlike other thoracic malignancies, seeding malignant cells along surgical tracts is a known complication of invasive diagnostic or therapeutic procedures for pleural mesothelioma (PM). We report the tract dissemination rate and risk factors in 308 consecutive patients treated over 9 years in a single institution who underwent pleurectomy decortication (PD). : Clinical and outcome data were reviewed. Fisher's exact test, Kaplan-Meier estimators, and log-rank tests were used to identify significant risk factors for surgical tract dissemination and to compare overall survival. : There were 233 males (75.6%), 187 right-sided operations (61%), 190 (61.7%) epithelioid histology cases, and the median age was 69 (29-84). During the study, malignant cell dissemination in resected surgical tracts was diagnosed in 69 (22.4%) patients. The dissemination rates in epithelioid, biphasic, and sarcomatoid tumors were 24.7%, 20.4%, and 0%, respectively. Disseminated malignant surgical tract was associated with advanced nodal status ( = 0.001), advanced staging by the American Joint Committee on Cancer (AJCC 8th edition, = 0.03), female sex (0.02), side of surgery ( = 0.03), and the number of video-assisted thoracoscopic surgery (VATS) ports ( = 0.003). In epithelioid mesothelioma, the median survival from diagnosis was 19.7 months in patients with tract seeding versus 36.3 months in patients without seeding (hazard ratio, 1.9; = 0.001). : Procedure tract dissemination occurs in almost every fourth patient with pleural mesothelioma and is associated with shorter overall survival in the epithelioid subtype.
与其他胸部恶性肿瘤不同,沿手术路径播散恶性细胞是胸膜间皮瘤(PM)侵入性诊断或治疗程序的一种已知并发症。我们报告了在单一机构中9年间连续接受胸膜剥脱术(PD)治疗的308例患者的手术路径播散率及危险因素。:回顾临床和结局数据。采用Fisher精确检验、Kaplan-Meier估计法和对数秩检验来确定手术路径播散的显著危险因素并比较总生存期。:男性233例(75.6%),右侧手术187例(61%),上皮样组织学类型病例190例(61.7%),中位年龄为69岁(29 - 84岁)。研究期间,69例(22.4%)患者被诊断出切除的手术路径中有恶性细胞播散。上皮样、双向性和肉瘤样肿瘤的播散率分别为24.7%、20.4%和0%。手术路径播散的恶性肿瘤与晚期淋巴结状态(P = 0.001)、美国癌症联合委员会(AJCC第8版)的晚期分期(P = 0.03)、女性(P = 0.02)、手术侧别(P = 0.03)以及电视辅助胸腔镜手术(VATS)端口数量(P = 0.003)相关。在上皮样间皮瘤中,手术路径有播散的患者从诊断起的中位生存期为19.7个月,无播散患者为36.3个月(风险比,1.9;P = 0.001)。:手术路径播散几乎发生在每四分之一的胸膜间皮瘤患者中,并且与上皮样亚型的总生存期较短相关。